CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?
Brain
Susan D
SD
Centre for Cardiovascular Biology & Medicine, New Hunt's House, King's College, Guy's Campus, SE1 1UL., London, UK. sue.brain@kcl.ac.uk
Poyner
David R
DR
Hill
Raymond G
RG
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology / Q000502:physiology; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D022761:Gene Transfer, Horizontal / Q000502:physiology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D008881:Migraine Disorders / Q000188:drug therapy*; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D011799:Quinazolines / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits; D058261:Receptor Activity-Modifying Proteins; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000737:chemistry / Q000502:physiology; D013045:Species Specificity; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D010879:Piperazines; D011799:Quinazolines; D058261:Receptor Activity-Modifying Proteins; D018015:Receptors, Calcitonin Gene-Related Peptide; D015740:Calcitonin Gene-Related Peptide; C406305:olcegepant